Gastritis is an extremely rare adverse effect of pembrolizumab. When patients receiving pembrolizumab complain of abdominal symptoms, endoscopy, tissue biopsy, and immunohistochemical staining should be actively performed for early identification and diagnosis of gastritis.
Keyphrases
- helicobacter pylori
- helicobacter pylori infection
- advanced non small cell lung cancer
- high glucose
- diabetic rats
- epidermal growth factor receptor
- ultrasound guided
- emergency department
- adipose tissue
- drug induced
- sleep quality
- oxidative stress
- small bowel
- bioinformatics analysis
- flow cytometry
- endothelial cells
- depressive symptoms
- adverse drug
- stress induced